POAI
Income statement / Annual
Last year (2024), Predictive Oncology Inc.'s total revenue was $1.62 M,
a decrease of 8.78% from the previous year.
In 2024, Predictive Oncology Inc.'s net income was -$12.20 M.
See Predictive Oncology Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$1.62 M |
$1.78 M |
$1.51 M |
$1.42 M |
$1.25 M |
$1.41 M |
$1.41 M |
$654.84 K |
$456.50 K |
$654.35 K |
| Cost of Revenue |
$826.14 K
|
$634.80 K
|
$505.11 K
|
$487.02 K
|
$447.19 K
|
$531.81 K
|
$415.76 K
|
$148.05 K
|
$181.62 K
|
$303.98 K
|
| Gross Profit |
$797.68 K
|
$1.15 M
|
$1.00 M
|
$933.66 K
|
$805.08 K
|
$879.76 K
|
$995.89 K
|
$506.79 K
|
$274.88 K
|
$350.37 K
|
| Gross Profit Ratio |
0.49
|
0.64
|
0.66
|
0.66
|
0.64
|
0.62
|
0.71
|
0.77
|
0.6
|
0.54
|
| Research and Development Expenses |
$0.00
|
$188.31 K
|
$320.32 K
|
$315.85 K
|
$2.35 M
|
$2.96 M
|
$1.86 M
|
$289.00 K
|
$406.00 K
|
$261.00 K
|
| General & Administrative Expenses |
$7.42 M
|
$8.38 M
|
$11.11 M
|
$10.93 M
|
$10.35 M
|
$9.78 M
|
$4.63 M
|
$7.25 M
|
$5.17 M
|
$4.25 M
|
| Selling & Marketing Expenses |
$1.47 M
|
$1.49 M
|
$1.36 M
|
$774.53 K
|
$584.94 K
|
$1.91 M
|
$2.37 M
|
$1.00 M
|
$467.97 K
|
$503.99 K
|
| Selling, General & Administrative Expenses |
$8.89 M
|
$9.87 M
|
$12.47 M
|
$11.71 M
|
$10.94 M
|
$11.69 M
|
$7.00 M
|
$8.25 M
|
$5.64 M
|
$4.75 M
|
| Other Expenses |
$2.85 M
|
$0.00
|
$3.80 M
|
$2.70 M
|
$0.00
|
$0.00
|
$68.48 K
|
$0.00
|
$1.16 M
|
$0.00
|
| Operating Expenses |
$11.74 M
|
$15.23 M
|
$16.27 M
|
$14.41 M
|
$13.29 M
|
$14.65 M
|
$8.86 M
|
$8.25 M
|
$6.80 M
|
$4.75 M
|
| Cost And Expenses |
$11.74 M
|
$15.86 M
|
$16.77 M
|
$14.89 M
|
$13.74 M
|
$15.19 M
|
$9.27 M
|
$8.40 M
|
$6.98 M
|
$5.05 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$10.65 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$3.00
|
$390.89 K
|
| Depreciation & Amortization |
$695.66 K
|
$739.32 K
|
$1.31 M
|
$1.34 M
|
$1.02 M
|
$704.88 K
|
$147.63 K
|
$71.56 K
|
$82.36 K
|
$78.57 K
|
| EBITDA |
-$10.16 M |
-$13.18 M |
-$13.95 M |
-$12.13 M |
-$11.46 M |
-$12.41 M |
-$7.71 M |
-$5.98 M |
-$6.44 M |
-$4.32 M |
| EBITDA Ratio |
-6.26
|
-7.41
|
-9.27
|
-8.54
|
-9.15
|
-8.79
|
-5.46
|
-9.14
|
-14.12
|
-6.6
|
| Operating Income Ratio |
-6.74
|
-7.91
|
-10.14
|
-9.48
|
-0.53
|
-9.76
|
-5.57
|
-11.83
|
-14.3
|
-6.72
|
| Total Other Income/Expenses Net |
$79.27 K
|
$100.27 K
|
-$10.47 M
|
-$6.85 M
|
-$13.40 M
|
-$5.62 M
|
-$2.23 M
|
$50.51 K
|
-$3.00
|
-$390.89 K
|
| Income Before Tax |
-$10.86 M
|
-$13.98 M
|
-$25.74 M
|
-$20.32 M
|
-$25.88 M
|
-$19.39 M
|
-$10.09 M
|
-$7.75 M
|
-$6.53 M
|
-$4.79 M
|
| Income Before Tax Ratio |
-6.69
|
-7.86
|
-17.1
|
-14.3
|
-20.67
|
-13.74
|
-7.15
|
-11.83
|
-14.3
|
-7.32
|
| Income Tax Expense |
$0.00
|
$0.00
|
$10.47 M
|
-$661.66 K
|
$11.82 M
|
$8.17 M
|
$0.00
|
$50.50 K
|
$0.00
|
$0.00
|
| Net Income |
-$12.20 M
|
-$13.98 M
|
-$36.21 M
|
-$19.66 M
|
-$37.70 M
|
-$27.56 M
|
-$10.09 M
|
-$7.75 M
|
-$6.53 M
|
-$4.79 M
|
| Net Income Ratio |
-7.51
|
-7.86
|
-24.05
|
-13.84
|
-30.11
|
-19.52
|
-7.15
|
-11.83
|
-14.3
|
-7.32
|
| EPS |
-2.32 |
-3.48 |
-6.98 |
-7.16 |
-44.25 |
-137.14 |
-157.4 |
-188.69 |
-462.28 |
0 |
| EPS Diluted |
-2.32 |
-3.48 |
-6.98 |
-7.2 |
-44.25 |
-137.2 |
-157.4 |
-188.69 |
-462.28 |
0 |
| Weighted Average Shares Out |
$5.45 M
|
$4.01 M
|
$3.69 M
|
$2.73 M
|
$584.98 K
|
$141.33 K
|
$64.08 K
|
$31.82 K
|
$14.12 K
|
$0.00
|
| Weighted Average Shares Out Diluted |
$5.45 M
|
$4.01 M
|
$3.69 M
|
$2.74 M
|
$597.51 K
|
$143.51 K
|
$64.08 K
|
$31.82 K
|
$14.12 K
|
$0.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
